![](/img/cover-not-exists.png)
A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer’s Disease in Taiwan
Chang, Chiung-Chih, Peng, Giia-Sheun, Lai, Te-Jen, Li, Chien-Hsun, Liu, Ching-KuanJournal:
Advances in Therapy
DOI:
10.1007/s12325-019-00939-0
Date:
April, 2019
File:
PDF, 454 KB
2019